Alpha-2 Plasmin Inhibitor, Plasma
Test Catalog Information
| Test Catalog Synonyms | |
| EPIC Synonyms |
A2PI Alpha 2 Antiplasmin A2A |
| Cerner Primary Mnemonic | Alpha 2 Antiplasmin |
| EPIC Display Name | Alpha-2 Plasmin Inhibitor, Plasma |
| Allscripts (AEHR) Order Name | Alpha 2 Antiplasmin |
| Sunrise Clinical Manager (SCM) Order Name | Alpha 2 Antiplasmin |
| EPIC Inpatient Orderable | Yes |
| EPIC Outpatient Orderable | Yes |
| Cerner Results |
ANTIPLAS |
| Clinical Info |
Diagnosing congenital alpha-2 plasmin inhibitor deficiencies (rare) Providing a more complete assessment of disseminated intravascular coagulation, intravascular coagulation and fibrinolysis, or hyperfibrinolysis (primary fibrinolysis), when measured in conjunction with fibrinogen, fibrin D-dimer, fibrin degradation products, soluble fibrin monomer complex, and plasminogen Evaluating liver disease Evaluating the effects of fibrinolytic or antifibrinolytic therapy |
| Specimen Type | |
| Container |
Blue Top Tube |
| Collection Instructions |
See Coagulation Studies in Special Instructions: Guidelines for |
| Transport Instructions | |
| Specimen Stability | |
| Methodology |
Chromogenic |
| Days Performed |
Monday through |
| Performing Laboratory |
Mayo Medical Laboratories |
| CPT |
85410; LOINC Code: 27810-1; |
| PDM |
5601205 |
Desired Epic Build Alpha-2 Plasmin Inhibitor, Plasma
| Cerner Primary Mnemonic: | Alpha 2 Antiplasmin | ||||||
| PDM | 5601205 | ||||||
| Informatics - Workgroup | Chemistry | ||||||
| Synonyms * | A2PI Alpha 2 Antiplasmin A2A | ||||||
| Display Name * | Alpha-2 Plasmin Inhibitor, Plasma | ||||||
| Order Entry Specimen Sources * | |||||||
| Order Entry Specimen Types |
Blood
| ||||||
| Specimen Navigator Specimen Types | |||||||
| Specimen Navigator Specimen Sources | |||||||
| Specimen Navigator Short Name | |||||||
| Ordering info (EPIC SmartText) | Diagnosing congenital alpha-2 plasmin inhibitor deficiencies (rare) Providing a more complete assessment of disseminated intravascular coagulation, intravascular coagulation and fibrinolysis, or hyperfibrinolysis (primary fibrinolysis), when measured in conjunction with fibrinogen, fibrin D-dimer, fibrin degradation products, soluble fibrin monomer complex, and plasminogen Evaluating liver disease Evaluating the effects of fibrinolytic or antifibrinolytic therapy | ||||||
| IP Orderable | Yes | ||||||
| OP Orderable | Yes | ||||||
|
AOEs * | |||||||
| AP AOEs | |||||||
| Special History | No | ||||||
| Build Comments | |||||||
| Filter * | |||||||
| Procedure Category Change | |||||||
Cerner Results
| |||||||
Current Actual EPIC Build as of 10/28/2024
| Procedure Id | 56356 | ||||||||||||
| Pdm | 5601205 | ||||||||||||
| Order Display Name | Alpha-2 Plasmin Inhibitor, Plasma | ||||||||||||
| Procedure Name | ALPHA-2 ANTIPLASMIN | ||||||||||||
| Procedure Master Number | LAB1123 | ||||||||||||
| Short Procedure Name | ALPHA-2 ANTI | ||||||||||||
| Category Code | 1.0 | ||||||||||||
| Category Code Record Name | LAB BLOOD ORDERABLES | ||||||||||||
| Synonyms | A2PI ALPHA 2 ANTIPLASMIN A2A | ||||||||||||
| Clinically Active | Yes | ||||||||||||
| Orderable | Yes | ||||||||||||
| Performable | Yes | ||||||||||||
| Filter Genomics | |||||||||||||
| Reference Link Url | https://labs.northwell.edu/epic/test/56356 | ||||||||||||
| Ordering Instructions | |||||||||||||
| Default Specimen Type | Blood | ||||||||||||
| Specimen Type Pick List | Blood | ||||||||||||
| Specimen Type List | |||||||||||||
| Op Specimen Type List | |||||||||||||
| Specimen Source Pick List | Blood, Arterial Blood, Capillary Blood, Central Line Blood, Venous | ||||||||||||
| Specimen Source Default - Male | Blood, Venous | ||||||||||||
| Specimen Source Default - Female | Blood, Venous | ||||||||||||
| Specimen Source List | |||||||||||||
| Op Specimen Source List | |||||||||||||
| Ip Lab Test Components For Report | |||||||||||||
| Op Lab Test Components For Report | |||||||||||||
| Order Questions | [] | ||||||||||||
| Order Questions Record Name | |||||||||||||
| Inpatient Order Questions | [] | ||||||||||||
| Inpatient Order Questions Record Name | |||||||||||||
| Order Specific Question Override | |||||||||||||
| Inpatient Question Override | |||||||||||||
| Location Restrict List Ip | |||||||||||||
| Location Restrict List Ip Record Name | |||||||||||||
| Location Restrict List Include Ip | |||||||||||||
| Location Restrict List Op | |||||||||||||
| Location Restrict List Op Record Name | |||||||||||||
| Location Restrict List Includes Op | |||||||||||||
| Edp Amb Order Specific Questions Record Name | |||||||||||||
| Edp Ip Order Specific Questions Record Name | |||||||||||||
| Edp Ip Specimen Source | Blood, Venous Blood, Central Line Blood, Arterial Blood, Capillary | ||||||||||||
| Edp Op Specimen Source | |||||||||||||
| Edp Ip Specimen Type | Blood | ||||||||||||
| Edp Op Specimen Type | |||||||||||||
| Derived Edp Ip Buttons S | Blood, Central Line Blood, Venous Blood, Capillary Blood, Arterial | ||||||||||||
| Derived Edp Ip Buttons T | Blood | ||||||||||||
| Derived Edp Op Buttons S | |||||||||||||
| Derived Edp Op Buttons T | |||||||||||||
| Ip Orderable | 1 | ||||||||||||
| Op Orderable | 1 | ||||||||||||
| EPIC OP AOEs | |||||||||||||
| EPIC IP AOEs | |||||||||||||
EPIC Components (results)
| |||||||||||||